Despite these mechanisms of immune suppression, our report is the first to demonstrate that an extracranial abscopal effect can still be elicited by brain radiotherapy alone in a patient with lung adenocarcinoma and PD-L1 TPS ≥50%, even before systemic immunotherapy was initiated. This evidence concerns the gene CD274 and lung adenocarcinoma.